In this study, We comprehensively analyzed 20 genes from The Cancer Genome Atlas(TCGA) HNSCC database (YTHDF1, FTO, YTHDF2, YTHDF3, HNRNPA2B1, METTL14, METTL3, IGF2BP1, HNRNPC, IGF2BP2, RBMX, IGF2BP3, YTHDC1, YTHDC2, RBM15, RBM15B, VIRMA,ZC3H13,WTAP,ALKBH5) to predict whether there is an impact on the prognosis of patients with HNSCC. The importance of 20 m6A regulators such as VIRMA in the pathogenesis of HNSCC was emphasized. These findings will provide a therapeutic approach and new research direction for the expression of m6A in patients with HNSCC and its prognosis.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: